Table 1 Baseline characteristics of LT patients.

From: The plasma degradome reflects later development of NASH fibrosis after liver transplant

 

Non-fibrotic

fibrotic

P-value

Age

62 ± 7

54 ± 14

0.12

M/F

5/5

6/6

1.0

Etiology

NASH 4

ALD 2

HCV 1

Autoimmune 0

Other 1

Cryptogenic 2

NASH 1

ALD 1

HCV 2

Autoimmune 4

Other 1

Cryptogenic 3

0.16

BMI

30 ± 5

28 ± 5

0.39

Bariatric surgery

0%

8%

0.54

  1. All assessments were prior to liver transplantation. All transplant recipients were from living donors (LDLT). There were no differences in key baseline characteristics between transplant recipients that developed fibrosis (F ≥ 2 progressors) and those who did not. There were no patients with diabetes mellitus at baseline. Among the group of progressors, 4 recipients (33%) ultimately developed cirrhosis.
Back to article page